TLLPharmaceuticals
Trident Lifeline Ltd — Cash Flow Statement
₹268.35
+5.50%
Trident Lifeline Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -21.34 Cr | -15.67 Cr | -25.92 Cr | -0.67 Cr | — |
| Capital Expenditure | -11.10 Cr | -17.89 Cr | -6.92 Cr | -0.46 Cr | — |
| End Cash Position | 2.46 Cr | 6.65 Cr | 13.78 Cr | 0.16 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | -1000.00 | -1000.00 | — | -2000.00 |
| Beginning Cash Position | 6.77 Cr | 13.78 Cr | 0.18 Cr | 0.01 Cr | — |
| Changes In Cash | -4.31 Cr | -7.13 Cr | 13.60 Cr | 0.14 Cr | — |
| Financing Cash Flow | 19.76 Cr | 11.01 Cr | 42.28 Cr | 0.80 Cr | — |
| Interest Paid Cff | -3.99 Cr | -0.60 Cr | -0.47 Cr | -0.13 Cr | — |
| Net Common Stock Issuance | 0.09 Cr | 0.99 Cr | 4.92 Cr | 3.00 Cr | — |
| Net Issuance Payments Of Debt | 23.66 Cr | 10.62 Cr | 5.99 Cr | -2.07 Cr | — |
| Net Short Term Debt Issuance | 7.46 Cr | 1.78 Cr | 1.92 Cr | 0.60 Cr | — |
| Net Long Term Debt Issuance | 16.19 Cr | 8.84 Cr | 4.07 Cr | -2.67 Cr | — |
| Investing Cash Flow | -13.82 Cr | -20.36 Cr | -9.69 Cr | -0.45 Cr | — |
| Net Other Investing Changes | 1000.00 | 1000.00 | -1000.00 | — | — |
| Interest Received Cfi | 2.62 Cr | 1.46 Cr | 0.76 Cr | 0.00 | — |
| Net Investment Purchase And Sale | -8.66 Cr | -0.49 Cr | -3.34 Cr | 0.00 | — |
| Purchase Of Investment | -8.66 Cr | -0.49 Cr | -3.34 Cr | 0.00 | — |
| Net PPE Purchase And Sale | -11.10 Cr | -17.89 Cr | -6.92 Cr | -0.46 Cr | — |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of PPE | -11.10 Cr | -17.89 Cr | -6.92 Cr | -0.46 Cr | — |
| Operating Cash Flow | -10.24 Cr | 2.23 Cr | -19.00 Cr | -0.21 Cr | — |
| Taxes Refund Paid | -4.54 Cr | -2.38 Cr | -0.54 Cr | 0.14 Cr | — |
| Change In Working Capital | -24.82 Cr | -2.94 Cr | -24.52 Cr | -3.72 Cr | — |
| Change In Other Current Liabilities | -4.87 Cr | 2.70 Cr | 1.85 Cr | -2.32 Cr | — |
| Change In Other Current Assets | -1.20 Cr | -0.87 Cr | -3.28 Cr | -0.56 Cr | — |
| Change In Payable | 6.40 Cr | 2.73 Cr | -0.42 Cr | 1.21 Cr | — |
| Change In Inventory | -7.84 Cr | -5.42 Cr | -3.46 Cr | 1.56 Cr | — |
| Change In Receivables | -18.22 Cr | -3.57 Cr | -19.00 Cr | -3.90 Cr | — |
| Other Non Cash Items | 1.36 Cr | -0.85 Cr | -0.29 Cr | 0.13 Cr | — |
| Depreciation And Amortization | 5.49 Cr | 0.97 Cr | 0.36 Cr | 0.20 Cr | — |
| Depreciation | 5.49 Cr | 0.97 Cr | 0.36 Cr | 0.20 Cr | — |
| Net Income From Continuing Operations | 13.61 Cr | 8.70 Cr | 6.58 Cr | 2.98 Cr | — |
| Issuance Of Debt | — | 10.62 Cr | 7.16 Cr | 1.03 Cr | — |
| Issuance Of Capital Stock | — | 49000.00 | 4.92 Cr | 3.00 Cr | 1.90 Cr |
| Net Other Financing Charges | — | -1000.00 | 31.84 Cr | -1000.00 | — |
| Common Stock Issuance | — | 49000.00 | 4.92 Cr | 3.00 Cr | 1.90 Cr |
| Short Term Debt Issuance | — | 1.30 Cr | 1.92 Cr | 0.60 Cr | — |
| Long Term Debt Issuance | — | 9.32 Cr | 5.24 Cr | 0.44 Cr | — |
| Repayment Of Debt | — | — | -1.17 Cr | -3.10 Cr | — |
| Long Term Debt Payments | — | — | -1.17 Cr | -3.10 Cr | — |
| Amortization Cash Flow | — | — | — | 0.12 Cr | 0.08 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Trident Lifeline Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.